Cervical cancer trends in the United States: a 35-year population-based analysis
- PMID: 22816437
- PMCID: PMC3521146
- DOI: 10.1089/jwh.2011.3385
Cervical cancer trends in the United States: a 35-year population-based analysis
Abstract
Purpose: To analyze trends in invasive cervical cancer incidence by age, histology, and race over a 35-year period (1973-2007) in order to gain insight into changes in the presentation of cervical cancer.
Methods: Data from the nine Surveillance, Epidemiology, and End Results (SEER) registries that continuously collected information on invasive cervical cancer were analyzed for trends. Standardized to the 2000 U.S population, annual age-adjusted incidence rates were estimated by race and histologic subtype. Histologic subtype was classified into squamous, adenocarcinoma, and adenosquamous.
Results: Overall incidence rates for invasive cervical cancer decreased by 54% over the 35 years, from 13.07/100,000 (1973-1975) to 6.01/100,000 (2006-2007), and the incidence rates declined by 51% and 70.2%, respectively, among whites and blacks. The incidence rates for squamous carcinoma decreased by 61.1% from 10.2/100,000 (1973-1975) to 3.97/100,000 (2006-2007). Incidence rates for adenosquamous cell carcinomas decreased by 16% from 0.27/100,000 (1973-1975) to 0.23/100,000 (2006-2007), and incidence rates for adenocarcinomas increased by 32.2% from 1.09/100,000 (1973-1975) to 1.44/100,000 (2006-2007). This increase in adenocarcinomas was due to an increase in incidence in white women; a decrease in incidence was observed for black women.
Conclusions: Although marked reductions in the overall and race-specific incidence rates of invasive cervical cancer have been achieved, they mask important variation by histologic subtype. These findings suggest that alternatives to Pap smear-based screening, such as human papillomavirus (HPV) testing and HPV vaccination, need to be prioritized if adenocarcinomas of the cervix are to be controlled.
Figures
Similar articles
-
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.Cancer. 2004 Mar 1;100(5):1035-44. doi: 10.1002/cncr.20064. Cancer. 2004. PMID: 14983500
-
Prognostic significance of adenocarcinoma histology in women with cervical cancer.Gynecol Oncol. 2012 May;125(2):287-91. doi: 10.1016/j.ygyno.2012.01.012. Epub 2012 Jan 18. Gynecol Oncol. 2012. PMID: 22266551
-
Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.Prev Med. 2019 Jun;123:316-323. doi: 10.1016/j.ypmed.2019.04.010. Epub 2019 Apr 16. Prev Med. 2019. PMID: 31002830
-
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107. Semin Surg Oncol. 1994. PMID: 8115784 Review.
-
The role of race/ethnicity in the epidemiology of esophageal cancer.J Assoc Acad Minor Phys. 2000;11(2-3):32-7. J Assoc Acad Minor Phys. 2000. PMID: 10953542 Review.
Cited by
-
Cervical Cancer Screening and Prevention Uptake in Females with Autism Spectrum Disorder.J Autism Dev Disord. 2024 Sep 18. doi: 10.1007/s10803-024-06565-2. Online ahead of print. J Autism Dev Disord. 2024. PMID: 39294385
-
Paired box proteins as diagnostic biomarkers for endocervical adenocarcinoma.World J Clin Cases. 2024 Sep 16;12(26):5854-5858. doi: 10.12998/wjcc.v12.i26.5854. World J Clin Cases. 2024. PMID: 39286388 Free PMC article.
-
Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma.Front Cell Infect Microbiol. 2024 Aug 16;14:1440017. doi: 10.3389/fcimb.2024.1440017. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39220287 Free PMC article.
-
Impact of baseline lymphopenia on outcomes of definitive treatment for locally advanced cervical cancer.Gynecol Oncol Rep. 2024 Jun 28;54:101448. doi: 10.1016/j.gore.2024.101448. eCollection 2024 Aug. Gynecol Oncol Rep. 2024. PMID: 39040940 Free PMC article.
-
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth.Cancer Sci. 2024 Oct;115(10):3273-3287. doi: 10.1111/cas.16264. Epub 2024 Jul 22. Cancer Sci. 2024. PMID: 39038813 Free PMC article.
References
-
- Jemal A. Bray F. Center MM. Ferlay J. Ward E. Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Siegel R. Naishadham D. Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Howlader N. Noone AM. Krapcho M, et al. Bethesda, MD: National Cancer Institute; 2011. SEER cancer statistics review 1975–2008.
-
- Barnholtz-Sloan J. Patel N. Rollison D. Kortepeter K. MacKinnon J. Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009;20:1129–1138. - PubMed
